未登录

G

Gary Wildey

case western reserve university

H指数:23

被引数:2,244

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retinoblastoma Proficient Small Cell Carcinoma: A Novel Entity with Therapeutic Vulnerability?

视网膜母细胞瘤功能完整型小细胞癌：一种具有治疗易感性的新型实体？

Journal of Thoracic Oncology

IF20.8

2026-04-020

PRE

Assessment of targets of antibody drug conjugates in SCLC

NPJ PRECISION ONCOLOGY

IF8

2025-01-020

OAAI

Identification of HEPACAM2 as a novel and specific marker of small cell carcinoma

IF5.1

2024-09-201

OAAI

Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2022-11-1814

OA

CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer

BRITISH JOURNAL OF CANCER

IF6.8

2020-12-017

OAAI

Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer

MOLECULAR ONCOLOGY

IF4.5

2020-11-2710

OAAI

Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma

MOLECULAR ONCOLOGY

IF4.5

2018-10-2315

OAAI

RUNX1T1 is amplified in combined small cell lung cancer

CANCER RESEARCH

IF16.6

2018-07-010

PRE

The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH1 Expression and Targeting Tumor-Initiating Cells

CANCER RESEARCH

IF16.6

2018-04-3039

OAAI

Post-transcriptional regulation on PIAS3 expression in malignant mesothelioma

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Genomic alterations in small cell lung cancer and their clinical relevance

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2016-08-013

OAAI

Targeting FACT complex with CBL0137 to overcome acquired resistance to EGFR-TKI in lung adenocarcinoma

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Clinical correlation of extensive-stage small-cell lung cancer genomics

ANNALS OF ONCOLOGY

IF65.4

2016-04-0174

OAAI

Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263

CELL DEATH & DISEASE

IF9.6

2015-12-3145

OAAI

CD30 Is a Potential Therapeutic Target in Malignant Mesothelioma

MOLECULAR CANCER THERAPEUTICS

IF5.5

2015-03-0922

OAAI

Transforming growth factor β (TGFβ)-induced apoptosis The rise & fall of Bim

IF3.4

2014-10-2887

OAAI

Bioinformatic analysis identifies polo-like kinase as a therapeutic target in small-cell lung cancer

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival

CLINICAL CANCER RESEARCH

IF10.2

2014-09-3040

OAAI

PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2013-09-2315

OAAI

Runx1 Is a Co-activator with FOXO3 to Mediate Transforming Growth Factor β (TGFβ)-induced Bim Transcription in Hepatic Cells

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2009-07-0155

OAAI